Novel engineered nanoparticles have the ability to selectively deliver immune checkpoint blockade (ICB) therapy to tumors, allowing for targeted immunotherapy that is more efficient and has reduced side effects.
A novel Ebola vaccine demonstrates highly effective immunization against the virus, completely protecting all tested patients from infection, and is stable for long periods at refrigerator temperatures, marking a new milestone in the battle against this deadly disease.
Subcutaneous allergen immunotherapy has been demonstrated to be a safe and effective treatment for individuals allergic to a common fungus.
A therapy for steroid-refractory and/or resistant Graft-versus-Host-Disease may function by favorably altering a population of circulating white blood cells.
CAR T Cells Show Efficacy for the Treatment of Relapsed and/or Refractory Aggressive Large B Cell Lymphoma
CAR T cells continue to show efficacy for the treatment of relapsed and/or refractory large B cell lymphoma.